PVpharm services

PVpharm to provide pharmacovigilance and CTIS support to the Center for Human Drug Research of the Netherlands (CHDR).

  • Post published:January 24, 2023

We are happy to announce that PVpharm have enter in a new agreement with Center of Human Drug Research (CHDR) to provide safety and regulatory consulting. This prestigious foundation, based in Leiden (NL) and with three decades of history, provide scientific and material support to first steps of the drug development in humans (phase I and II of Clinical trials). Our collaboration will focus on helping about EMA’s Clinical Trial Information System (CTIS) and pharmacovigilance tasks, essential in these steps of drug development. With different therapeutic areas of research, CHDR is a leading organization in this field, with projects as…

Continue ReadingPVpharm to provide pharmacovigilance and CTIS support to the Center for Human Drug Research of the Netherlands (CHDR).

Faculty at Signal Management training by DIA November 2022

  • Post published:November 24, 2022

On 21-24 November 2022, José Ortiz provided the training faculty for the Signal Management training organized by DIA. This training provides knowledge over Signal Management to the participants, so they can apply the basic concepts and principles of signal detection in pharmacovigilance, from simple visualisation and tabulation methods to sophisticated data mining techniques. • Design the signal management process for institutions and companies of various sizes, portfolios and geographical presence, based on the possibilities and limitations of their data and resources • Understand key messages from the current European and US regulations on signal management, to best manage implications also…

Continue ReadingFaculty at Signal Management training by DIA November 2022

Round table and discussion – Differences between Phase III and Phase IV Drug Safety and Pharmacovigilance – University of Valladolid

  • Post published:November 12, 2022

José Alberto Ayala Ortiz, PVpharm CEO, will participate together with Andrea Álvarez, QPPV of FAES FARMA in a Round table and discussion about "Differences between Phase III and Phase IV Drug Safety and Pharmacovigilance" organized by the University of Valladolid. The conference will be held on 17th November 2022 at 18:00 CET, and it is free of access!! Please join here. https://forms.gle/FEDtVzLfZJfBxq448?fbclid=IwAR1eQx0ISwSau6DZmHZ-ZszE4-QJPcMpfm9wuXa2pMCinMTg0U8LGmTnQNo PVpharm is also organizing in-house trainings in pharmacovigilance for pharmaceutical companies and CROs, please contact us for further information.

Continue ReadingRound table and discussion – Differences between Phase III and Phase IV Drug Safety and Pharmacovigilance – University of Valladolid
DIA QPPV forum 2022 – No slides presentation
QPPV Forum 2022

DIA QPPV forum 2022 – No slides presentation

  • Post published:November 7, 2022

José Ortiz, PVpharm CEO, participated one more time as a speaker in the QPPV forum 2022 organized by DIA. https://www.diaglobal.org/en/conference-listing/meetings/2022/11/global-forum-for-qualified-persons-for-pharmacovigilance-qppv José presented in the Session 2: Pharmacovigilance System Oversight on 09 Nov 2022 9:00 AM – 09 Nov 2022 10:30 AM together with other key speakers as: -Sina Schader, DrMed EU and UK QPPV Abbvie, Germany -Gabrielle Amselem Deputy EU/UK QPPV Alexion, France -Hayley Fletcher Principal Quality Lead, PDQ Quality Assurance Process GVP Roche Products Ltd., United Kingdom Session chairs were: -Gemma Jimenez Sese Patient Safety Director, EU QPPV Almirall, S.A., Spain -Kiernan Trevett, MSc Principal Quality Lead, PDQ Quality…

Continue ReadingDIA QPPV forum 2022 – No slides presentation

DIA Pharmacovigilance System Master File (PSMF) virtual course (2-3 November 2022)

  • Post published:October 25, 2022

José Ortiz will be participating as a trainer together with Marcela Fialova and Claire Longman, MSc Interim Head of GCP and Senior Pharmacovigilance Inspector at the Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom in the Pharmacovigilance System Master File (PSMF) course organized by DIA. The training will be delivered online from 1:00 PM to 5:00 PM (CEST) on November 2 to 3, 2022. This virtual live training course covers essential concepts and guidance about the Pharmacovigilance System Master File (PSMF). This key document describes the company’s pharmacovigilance system, supporting, and documenting its compliance with the requirements laid down…

Continue ReadingDIA Pharmacovigilance System Master File (PSMF) virtual course (2-3 November 2022)

PVpharm at Farmaforum 2022 (Video)

  • Post published:October 18, 2022

PVpharm participated in the 2022 edition of FARMAFORUM. PVpharm presented their services. We created a VIDEO that you can see below. Pharmacovigilance and quality services GVP, GCP, GDP and GMP: As a Pharmacovigilance service provider, PVpharm offers a full range of PV services for the pharmaceutical industry, sponsors of clinical trials and other service provider companies. PVpharm also provides a risk-based Pharmacovigilance Audit Service, which focuses on the areas of highest risk to an organisation’s pharmacovigilance system, taking into account applicable local regulatory requirements. Our approach is risk and process based, our objective is to improve your pharmacovigilance system in order to…

Continue ReadingPVpharm at Farmaforum 2022 (Video)
José Ortiz to participate as a speaker in the DIA QPPV forum 2022
Jose Ortiz will be presenting on the QPPV forum 2022 organized by DIA

José Ortiz to participate as a speaker in the DIA QPPV forum 2022

  • Post published:September 17, 2022

José Ortiz, PVpharm CEO will participate one more time as a speaker in the next QPPV forum organized by DIA. You can find more information in the link: https://www.diaglobal.org/en/conference-listing/meetings/2022/11/global-forum-for-qualified-persons-for-pharmacovigilance-qppv José will be presenting in the Session 2: Pharmacovigilance System Oversight on 09 Nov 2022 9:00 AM – 09 Nov 2022 10:30 AM https://www.diaglobal.org/en/conference-listing/meetings/2022/11/global-forum-for-qualified-persons-for-pharmacovigilance-qppv/agenda/09/session-2-pharmacovigilance-system-oversight?ref=Session2PharmacovigilanceSystemOversight About the QPPV forum: In a changing and expanding world, this is still the only forum designed for QPPVs by QPPVs, now celebrating its 16th year and still going strong. Back in a face-to-face format, it brings together QPPVs from all over the world to discuss how…

Continue ReadingJosé Ortiz to participate as a speaker in the DIA QPPV forum 2022

DIA Pharmacovigilance QMS virtual course (19-22 September 2022)

  • Post published:September 13, 2022

José Ortiz will be participating as a trainer together with Wendy Huisman in the Pharmacovigilance Quality Management System course organized by DIA. The training will be delivered online from 9:00 AM to 01:30 PM (CEST) on September 19 to 22, 2022. The course will employ a mix of informative sessions, real case studies, and hands-on interactive exercises where attendees will be able to apply what they have learned. Learners will leave the course with an understanding of how elements of the Pharmacovigilance and Quality Management Systems fit together to achieve regulatory compliance. Course Highlights Quality and the Quality SystemQMS OverviewPV…

Continue ReadingDIA Pharmacovigilance QMS virtual course (19-22 September 2022)